Alverno Clinical Laboratories, LLC

5 articles about Alverno Clinical Laboratories, LLC

• Ibex and Alverno Laboratories Sign Multi-Year, Multi-Tissue Expansion Agreement of AI for Cancer Diagnosis

  3/9/2023

  Alverno Laboratories and Ibex Medical Analytics today announced a new agreement to expand the deployment of Ibex's Galen™ suite of Artificial Intelligence (AI) solutions to the entire Alverno network across Illinois and Indiana.

• Alverno Laboratories Selects Ibex's AI Solution for Cancer Diagnostics

  8/11/2021

  Alverno Laboratories, a provider of high-quality diagnostic testing services and one of the largest integrated laboratory networks in the United States, and Ibex Medical Analytics, the market leader in artificial intelligence (AI)-powered cancer diagnostics, today announced a deal to deploy Ibex's AI-powered Galen™ platform, helping pathologists provide accurate diagnosis and improved care for cancer patients. 

• COPAN and Alverno Laboratories Partner to Successfully Validate PhenoMATRIX™ for Detection of Group A Streptococcus Using CHROMagar's COLOREX™ Media

  6/14/2019

  COPAN and Alverno Laboratories are proud to announce the successful evaluation of the novel COLOREX™ Strep A chromogenic medium using Artificial Intelligence and digital detection to pre-assess Throat Strep Screens in WASPLab™.

• Immucor and Alverno Clinical Laboratories, LLC Sign Five-Year Automation Agreement

  5/28/2009

• Beckman Coulter, Inc. (Jobs) in Pact with Alverno Clinical Laboratories, LLC

  9/27/2007